Evidence map›Paper›PMID 35281991›Full record

ReviewFrontiers in neurology2021

Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities.

Parastoo Amiri, Somayeh Kazeminasab, Seyed Aria Nejadghaderi, Reza Mohammadinasab, Hojjat Pourfathi, Mostafa Araj-Khodaei, Mark J M Sullman, Ali-Asghar Kolahi, Saeid Safiri

3 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 172 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 9 pooled it
42.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06162819 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis

TypeinterventionalSponsorShalamar Institute of Health SciencesRan2024 to 2024Enrolled84ConditionsMigraine, ProphylaxisArmsAmitriptyline, Flunarizine 5mg
NCT06197542 nacompletednot on this mapstarted 2023, after this paper: background citation

Effects of Active Release Technique and Instrument Assisted Soft Tissue Mobilization in Patients With Migraine

TypeinterventionalSponsorRiphah International UniversityRan2023 to 2023Enrolled54ConditionsMigraine DisordersArmsActive Release Technique, Instrument Assisted Soft Tissue Mobilization
NCT06905912 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Comparison Between FL41 Tinted Spectacles, Biomedics55 Premier Contact Lenses, and Altius Tinted Contact Lenses on Photophobia

TypeinterventionalSponsorUniversity of OklahomaRan2026 to 2027Enrolled200ConditionsPhotophobiaArmsBiomedics55 Premier contact lenses, and Altius Tinted Contact Lenses
3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 9 syntheses or guidelines pooled it, 309 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Migraine in the Corporate Sector: Prevalence, Risk Factors, Job Efficiency Impact, and Management Strategies.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  20. Review

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Parastoo AmiriResearch Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Somayeh KazeminasabResearch Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Seyed Aria NejadghaderiSchool of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Reza MohammadinasabDepartment of History of Medicine, School of Traditional Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Hojjat PourfathiDepartment of Anesthesiology and Pain Management, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Mostafa Araj-KhodaeiResearch Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Mark J M SullmanDepartment of Social Sciences, University of Nicosia, Nicosia, Cyprus.
Ali-Asghar KolahiSocial Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Saeid SafiriNeurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Tabriz University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRUniversal Scientific Education and Research Network · IRUniversity of Nicosia · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Migraine affects more than one billion individuals each year across the world, and is one of the most common neurologic disorders, with a high prevalence and morbidity, especially among young adults and females. Migraine is associated with a wide range of comorbidities, which range from stress and sleep disturbances to suicide. The complex and largely unclear mechanisms of migraine development have resulted in the proposal of various social and biological risk factors, such as hormonal imbalances, genetic and epigenetic influences, as well as cardiovascular, neurological, and autoimmune diseases. This review presents a comprehensive review of the most up-to-date literature on the epidemiology, and risk factors, as well as highlighting the gaps in our knowledge.

Indexed as

comorbidityepidemiologymigrainenarrative reviewrisk factors

Identifiers

PMID35281991
PMCPMC8904749
OpenAlexW4214623848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.